Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Evansville, Indiana 47710


This trial is conducted in United States of America (USA). The aim of this trial is to examine the bioequivalence of Norditropin® versus Genotropin® in healthy adult volunteers.


Inclusion Criteria: - Body mass index (BMI) 18.0-27.0 kg/m^2 (both inclusive) - Considered generally healthy upon completion of medical history, physical examination, vital signs, screening laboratory results, and electrocardiogram (ECG), as judged by the Investigator (trial physician) Exclusion Criteria: - The receipt of any investigational medicinal product within 1 month prior to this trial - Current or previous treatment with growth hormone or IGF-I (insulin-like growth factor-I) - Female of childbearing potential who is pregnant, breast-feeding or intends to become pregnant or is not using adequate contraceptive methods (adequate contraceptive measures as required by local law or practice) for the duration of the trial - Known presence or history of malignancy - Diabetes mellitus - Use of pharmacologic doses of glucocorticoids - Use of anabolic steroids - History of drug or alcohol abuse



Primary Contact:

Study Director
Global Clinical Registry (GCR, 1452)
Novo Nordisk A/S

Backup Contact:


Location Contact:

Evansville, Indiana 47710
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.